# Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

Study · id `cardio:ct-nct07476898` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07476898](<https://clinicaltrials.gov/study/NCT07476898>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07476898

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 864 participants.

## Technical summary

Registry record NCT07476898. Randomized; no masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2028-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 864 participants (planned count; ClinicalTrials.gov record NCT07476898, source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)
- Planned start: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT07476898, source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)
- Primary completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT07476898, source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)
- Completion: 2028-08-01 (anticipated) (ClinicalTrials.gov record NCT07476898, source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07476898, source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07476898-2026-03-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window
- Acronym: TIME-MINOR
- Condition: Stroke
- Intervention (Drug): Tenecteplase (0.25mg/kg)
- Intervention (Drug): Standard Medical Management
- Lead sponsor: First Hospital of China Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Tenecteplase (`cardio:tenecteplase`)
- Registry intervention is a member of this class by a sourced record link: Fibrinolytic (clot-dissolving) drugs (`cardio:fibrinolytic-clot-dissolving-drugs`)
- Registry lists this organization as the lead sponsor: First Hospital of China Medical University (`cardio:org-first-hospital-of-china-medical-university`)

## Provenance

Content hash: aef02ab8859a90412a4e376e11d255fd970d446b16d5f7f3acbf1ac340faa809
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
